LLM-Powered Clinical Trial Matching and Patient Recruitment
AI can dramatically accelerate clinical trial enrollment by matching patients to trials. Learn how LLMs are transforming recruitment from months to weeks.
The Recruitment Bottleneck
Clinical trial recruitment is the single biggest cause of drug development delays. 80% of trials fail to meet enrollment timelines, adding an average of 6 months to development schedules. Each day of delay costs sponsors $600K-$8M depending on the therapeutic area.
LLMs can address this bottleneck by automatically matching patients to trials based on complex eligibility criteria, medical history analysis, and geographic feasibility. This guide covers the practical implementation of AI-powered trial matching systems.
Eligibility Criteria Parsing
Clinical trial eligibility criteria are written in semi-structured natural language with complex logical conditions. LLMs excel at parsing these criteria into structured, computable rules. GPT-5 and Claude 4 can both decompose criteria like 'Patients aged 18-65 with confirmed HER2-positive breast cancer who have received at least two prior lines of therapy and have no history of cardiac events' into discrete, evaluable conditions.
The key challenge is handling ambiguity and implicit criteria. LLMs trained on historical trial protocols learn to identify implicit exclusions and standard-of-care requirements that aren't explicitly stated in eligibility criteria. This reduces false positive matches that waste investigator time.
Patient Record Analysis
Matching requires understanding patient medical records — EHR data, lab results, pathology reports, and imaging findings. LLMs can process unstructured clinical notes to extract relevant medical history, current conditions, and treatment history.
Privacy is paramount. The most successful implementations use on-premise LLMs (Llama 4, Qwen 3) that process patient data within the healthcare organization's infrastructure. De-identification pipelines remove patient identifiers before any cloud-based processing, ensuring HIPAA compliance.
Matching Algorithm Architecture
A production trial matching system combines LLM-based criteria parsing with structured database queries. The LLM converts eligibility criteria to executable rules; these rules are evaluated against the patient database. Candidates are ranked by match quality, geographic proximity, and investigator capacity.
The system should present matches to clinical coordinators with clear explanations of why each patient qualifies, which criteria are met with high confidence, and which require manual verification. This human-in-the-loop approach maintains safety while dramatically accelerating screening.
Results & Regulatory Considerations
Early implementations of LLM-powered trial matching report 40-60% reduction in screening time and 25-35% improvement in enrollment rates. The biggest impact is in rare disease trials and complex oncology studies where manual matching is most challenging.
Regulatory considerations: AI-assisted matching is an operational tool, not a medical device, but organizations should maintain audit trails of matching decisions and ensure that final enrollment decisions are made by qualified clinical staff. Document the AI system in the trial protocol as a recruitment tool.